Stock Events

GSK 

$39.16
7591
+$0.26+0.67% Friday 20:00

Statistics

Day High
39.51
Day Low
39.14
52W High
45.8
52W Low
32.69
Volume
2,512,005
Avg. Volume
3,475,133
Mkt Cap
81.16B
P/E Ratio
12.84
Dividend Yield
1.99%
Dividend
0.78

Upcoming

Dividends

1.99%Dividend Yield
10Y Growth
-4.43%
5Y Growth
-6.73%
3Y Growth
-10.96%
1Y Growth
9.42%

Earnings

1MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0
0
0
0.01
Expected EPS
0.004638451509377194
Actual EPS
0.005390632835222144

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GSK. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

48$Average Price Target
The highest estimate is $53.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
40%
Hold
60%
Sell
0%

About

Health Technology
Pharmaceuticals: Major
Manufacturing
Medicinal and Botanical Manufacturing
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Show more...
CEO
Emma Walmsley
Employees
70212
Country
US
ISIN
US37733W2044
WKN
000940610

Listings